Skip to main content
idi
Toggle navigation
0
You have 0 notifications
Site Visitor
Site Visitor
New To Inknowvation.com?
Register now to get an access to proprietary SBIR-STTR databases!
Registration is fast and free - start your access to business-actionable information today!
Login
Site Register
State Office
You are here:
Home
Analytics
State Office
×
Alert!
To view the full data details, please
Login
or
Register
.
Selection of Data Range
Life of Program Data
Last 5 Years Data
State
Synopsis: State SBIR-STTR Data
State Awardees
2,651
(7.89%)
Publicly Traded
147
VC Funded Firms
645
M&A Deals
379
Firms with IP
1,414
Total US patents
46,719
State Employment
53.31%
STEM Employment
8.84%
SBIR Employment
32.68%
State Data & Analysis
Click on the map OR choose State from menu below
Select State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
District of Columbia
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Awards Distribution by Agency
(over life of program)
Trending State Award Dollars
(5-yr increments)
Extent of SBIR involvement
Most Recent SBIR Projects
Title | Year | Agency | $$$ | Firm
High Energy Primary Battery for Navy Applications
2025
Navy
$697,885
Physical Sciences Inc
Navigation Warfare Situational Awareness with AI/ML
2025
Navy
$1,749,972
BlueRISC Inc
Aircraft Low Observable Battle-Damage Repair
2025
Navy
$999,630
Triton Systems Inc
Explanation
Featured SBIR Firm
Triterpenoid Therapeutics Inc
Triterpenoid Therapeutics, Inc. ("TTX") is a preclinical pharmaceutical company working on a synthetic triterpenoid drug that is orally bioavailable, effective in nanomolar doses, and is safely ingested at chronic dosage. Potentially relevant for use for multiple applications in oncology, Synthetic triterpenoids also have known anti-viral capacities. Studies for using 2P-Im as a treatment for COVID-19 commenced in June 2020. 2P-Im is a member of ...
see more
www.triterptx.com
| (802) 889-5567
SBIR Firms in the News
May
03
2023
Astronetx Celebrates Lunar Mobility Vehicle First Movers with Lockheed Martin
Feb
27
2023
Cambridge Semantics' AnzoGraph DB Named a Trend Setting Product for 2023
Feb
08
2023
ProterixBio Announces Commercial Offering of Quantitative Soluble ST2 Assay
Dec
20
2022
Nth Cycle Awarded $2.15 Million U.S. Department of Energy Grant
Dec
02
2022
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
State
Synopsis: State SBIR-STTR Data
State Awardees
807
Publicly Traded
13
VC Funded Firms
183
M&A Deals
19
Firms with IP
433
Total US patents
8,910
State Employment
53.31%
STEM Employment
8.84%
SBIR Employment
32.68%
State Data & Analysis
Click on the map OR choose State from menu below
Select State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
District of Columbia
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Awards Distribution by Agency
(last 5 years)
Trending State Award Dollars
(5-yr increments)
Extent of SBIR involvement
Most Recent SBIR Projects
Title | Year | Agency | $$$ | Firm
High Energy Primary Battery for Navy Applications
2025
Navy
$697,885
Physical Sciences Inc
Navigation Warfare Situational Awareness with AI/ML
2025
Navy
$1,749,972
BlueRISC Inc
Aircraft Low Observable Battle-Damage Repair
2025
Navy
$999,630
Triton Systems Inc
Featured SBIR Firm
Triterpenoid Therapeutics Inc
Triterpenoid Therapeutics, Inc. ("TTX") is a preclinical pharmaceutical company working on a synthetic triterpenoid drug that is orally bioavailable, effective in nanomolar doses, and is safely ingested at chronic dosage. Potentially relevant for use for multiple applications in oncology, Synthetic triterpenoids also have known anti-viral capacities. Studies for using 2P-Im as a treatment for COVID-19 commenced in June 2020. 2P-Im is a member of ...
see more
www.triterptx.com
| (802) 889-5567
SBIR Firms in the News
May
03
2023
Astronetx Celebrates Lunar Mobility Vehicle First Movers with Lockheed Martin
Feb
27
2023
Cambridge Semantics' AnzoGraph DB Named a Trend Setting Product for 2023
Feb
08
2023
ProterixBio Announces Commercial Offering of Quantitative Soluble ST2 Assay
Dec
20
2022
Nth Cycle Awarded $2.15 Million U.S. Department of Energy Grant
Dec
02
2022
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
Explanation
×
×
Login to your account
Mail sent successfully.
Enter any username and password.
Username
Password
Remember me
Login
Forgot your username?
Click here for assistance
Forgot your password?
Request new password
Don't have an account?
Sign up
Forgot username?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
Forgot password?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
